Larimar Therapeutics, Inc. — Proxy Solicitation & Information Statement 2020

Aug 19, 2020

DEFA14A 1 d37632ddefa14a.htm DEFA14A DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement
☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐	Definitive Proxy Statement
☒	Definitive Additional Materials
☐	Soliciting Material under Rule 14a-12

Larimar Therapeutics, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒	No fee required.
☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:
☐	Fee paid previously with preliminary materials.
☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing.
	(1)	Amount Previously Paid:
	(2)	Form, Schedule or Registration Statement No.:
	(3)	Filing Party:
	(4)	Date Filed:

***** Exercise Your** Right **to Vote *****

| LARIMAR THERAPEUTICS,

INC.	Meeting Information
	Meeting Type: Special Meeting
	For holders as of: August 12, 2020
	Date: September 29, 2020 Time: 9:00 AM EDT
	Location: Virtually via the
internet at:
	www.meetingcenter.io/202792612
	To access the
virtual meeting, you must refer to the
●	“General
Information” section of the proxy statement.
	You are receiving this communication
because you hold shares in the above named company.
	This is not a ballot. You cannot use
this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a
paper copy (see reverse side).
	We encourage you to access and review
all of the important information contained in the proxy materials before voting.
	See the reverse side of this notice to
obtain proxy materials and voting instructions.
	●

	— Before You Vote—
	How to Access the Proxy Materials
	Proxy Materials Available to VIEW or RECEIVE:
	1. Notice & Proxy Statement
	How to View
Online:
	Have the information that is printed in the box marked by the arrow (located on the following page) and visit: www.proxyvote.com.
	How to Request and Receive a PAPER
or E-MAIL Copy:
	If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy.
Please choose one of the following methods to make your request:
	1) BY INTERNET : www.proxyvote.com
	2) BY TELEPHONE : 1-800-579-1639
	3) BY E-MAIL* :
sendmaterial@proxyvote.com
	* If requesting materials by e-mail, please send a blank e-mail with the information that
is printed in the box marked by the arrow (located on the following page) in the subject line.
	Requests, instructions and other inquiries sent to this e-mail address will NOT be
forwarded to your investment advisor. Please make the request as instructed above on or before September 14, 2020 to facilitate timely delivery.
	—How To Vote —
●	Please Choose One of the Following Voting Methods
	Vote In Person: If you choose to vote these shares in person at the meeting, you must request a “ legal proxy. ” To do so,
please follow the instructions at www.proxyvote.com or request a paper copy of the materials, which will contain the appropriate instructions. Many shareholder meetings have attendance requirements including, but not limited to, the
possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance.
	Vote By Internet: To vote now by
Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow available and follow the instructions.	●
	Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a voting instruction form.

The Board of Directors
recommends
you vote FOR the following
proposal(s):
1. Approve the Larimar Therapeutics, Inc. 2020 Equity Incentive Plan and certain
conditional grants thereunder
NOTE: Such other business as may properly come before the meeting or any adjournment thereof.
●

Voting Instructions
●
THIS SPACE RESERVED FOR LANGUAGE PERTAINING TO BANKS AND BROKERS AS REQUIRED BY THE NEW YORK STOCK
EXCHANGE
	Broadridge Internal Use Only
THIS SPACE RESERVED FOR SIGNATURES IF APPLICABLE	Job #
	Envelope #
	Sequence #
	# of # Sequence #